Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Liver Diseases × Lead × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 4 Brain Neoplasms 3 Neoplasms 2 Thrombophilia 1 Stomatitis 1 Stomach Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Periodontitis 1 Neoplasms, Plasma Cell 1 Motor Activity 1 Lung Neoplasms 1 Liver Neoplasms 1 Liver Diseases 1 Head and Neck Neoplasms 1 Glioblastoma 1 Gastrointestinal Stromal Tumors 1 Febrile Neutropenia 1 EGFR-Mutant Lung Cancer 1 Deglutition Disorders 1 Communication Disorders 1 Colorectal Neoplasms 1 Central Nervous System Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Blood Coagulation Disorders 1

Interventions

Sorafenib 4 Blood Specimen Collection 4 lenvatinib 2 halofantrine 2 camrelizumab 2 Liver Transplantation 2 trametinib 1 toripalimab 1 titanium silicide 1 tislelizumab 1 sintilimab 1 pembrolizumab 1 ledipasvir, sofosbuvir drug combination 1 genexol-PM 1 gadolinium ethoxybenzyl DTPA 1 fluorocholine 1 bavituximab 1 atezolizumab 1 User-Centered Design 1 Sunitinib 1 Sufentanil 1 Sofosbuvir 1 Ropivacaine 1 Ribavirin 1 Radiotherapy 1 Radiosurgery 1 Portasystemic Shunt, Transjugular Intrahepatic 1 Patient Navigation 1 Nutritional Status 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05931068 2024-08-05

PRO-NRG

Academisch Ziekenhuis Maastricht

Gastrointestinal

Liver Diseases, Liver Neoplasms, Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡